Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients (PreCarVasc)

Central Hospital, Nancy, France

Status: Completed

Conditions: Patients Hospitalized for Pre-eclampsia

Treatments: Other: Patient with pre-eclampsia

Study type: Observational

Funder types: Other

Identifiers

NCT06059937

2023-A00933-42

Details and patient eligibility

About

Pre-eclampsia is a disease characterized by placental damage leading to a cascade of complications during pregnancy. It is initially manifested by high blood pressure and the presence of albumin in the urine. It can lead to emergency hospitalization in severe cases and cause major complications or even death in the mother and the fetus.

Several studies observing the outcome of patients with pre-eclampsia have shown an increased long-term cardiovascular risk in these patients, justifying regular medical follow-up with the treating physician and specialists, mainly cardiologists.

The main objective of this research is to describe the cardiovascular risk assessment actions implemented by the treating general practitioner in the year following pre-eclampsia (blood pressure measurement in the office, self-measurement of blood pressure, ABPM, cardiological consultation, biological monitoring of blood (creatininemia, LDL, fasting glycemia) or urine (albuminurie/creatininurie ratio), and screening and management of possible smoking).

Enrollment: 155 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients ≥ 18 years hospitalized for preeclampsia at the Nancy regional maternity hospital

Exclusion criteria

• Fetal death in utero;
• Adult Person subject to a legal protection measure (guardianship, curatorship, safeguard of justice);
• Person deprived of liberty by a judicial or administrative decision;
• Person subject to psychiatric care under constraint by virtue of articles L. 3212-1 and L. 3213-1 of the Public Health Code.